MO · News · 20260804N
Guidance / Outlook
ALTRIA GROUP, INC. · 2026-08-04 · Importance 51 · Surprise 60 · In source text
Altria’s second-quarter 2026 revenue and earnings were reported below Wall Street consensus on July 30, 2026. The company lowered its full-year outlook after previously reaffirming adjusted diluted EPS guidance of $5.56 to $5.72 on April 30, 2026. The results and guidance reduction prompted multiple law-firm investigations into whether Altria adequately disclosed risks surrounding its smoke-free product strategy and FDA authorization expectations.
Key facts
- Altria reported second-quarter earnings and revenue below consensus on July 30, 2026 and lowered its full-year outlook. source
- Management had reaffirmed on April 30, 2026 full-year adjusted diluted EPS guidance of $5.56 to $5.72. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | realized | — | Altria reported second-quarter earnings and revenue below consensus on July 30, 2026 and lowered its full-year outlook. |
| net_income | negative | realized | — | Altria reported second-quarter earnings and revenue below consensus on July 30, 2026 and lowered its full-year outlook. |
| revenue | negative | committed | — | Altria reported second-quarter earnings and revenue below consensus on July 30, 2026 and lowered its full-year outlook. |
| net_income | negative | committed | — | Altria reported second-quarter earnings and revenue below consensus on July 30, 2026 and lowered its full-year outlook. |